Childhood Leukemia, Lymphoma, and Histiocytosis

The Hematologic Malignancy Center at Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the top pediatric leukemia and lymphoma treatment centers in the world. In addition to treating blood cancers — leukemias and lymphomas — our center treats the primary types of histiocytosis, a disease that shares many of the characteristics of cancer and is generally treated using similar therapies. We treat these conditions:

Leukemia

• Leukemia (overview)
• Acute lymphoblastic leukemia (ALL), including relapsed acute lymphoblastic leukemia
• Acute myeloid leukemia (AML)
• Chronic myeloid leukemia (CML)
• Juvenile myelomonocytic leukemia

Learn about our Pediatric Leukemia Treatment Program

Lymphoma

• Hodgkin lymphoma
• Non-Hodgkin lymphomas
• Burkitt lymphoma
• Diffuse large B-cell lymphoma
• Primary mediastinal B-cell lymphoma
• Anaplastic large cell lymphoma
• Lymphoblastic lymphoma
• Rare non-Hodgkin lymphomas

Learn about our Pediatric Lymphoma Treatment Program

Histiocytosis

• Langerhans cell histiocytosis (LCH)
• Hemophagocytic lymphohistiocytosis (HLH)

Learn about our Pediatric Histiocytosis Treatment Program

Learn about our Node Assessment Program